Bioatla Stock Analysis
| BCAB Stock | USD 0.30 0.02 6.25% |
Bioatla holds a debt-to-equity ratio of 0.028. With a high degree of financial leverage come high-interest payments, which usually reduce Bioatla's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Bioatla's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Bioatla's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Bioatla Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Bioatla's stakeholders.
For most companies, including Bioatla, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Bioatla, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Bioatla's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Bioatla's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Bioatla is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Bioatla to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Bioatla is said to be less leveraged. If creditors hold a majority of Bioatla's assets, the Company is said to be highly leveraged.
Bioatla is undervalued with Real Value of 2.74 and Hype Value of 0.34. The main objective of Bioatla stock analysis is to determine its intrinsic value, which is an estimate of what Bioatla is worth, separate from its market price. There are two main types of Bioatla's stock analysis: fundamental analysis and technical analysis.
The Bioatla stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bioatla's ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. Bioatla Stock Analysis Notes
About 29.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.15. Bioatla had not issued any dividends in recent years. BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California. Bioatla operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. For more info on Bioatla please contact Jay Short at 858 558 0708 or go to https://www.bioatla.com.Bioatla Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bioatla's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bioatla or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Bioatla generated a negative expected return over the last 90 days | |
| Bioatla has high historical volatility and very poor performance | |
| Bioatla has some characteristics of a very speculative penny stock | |
| Bioatla has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 11 M. Net Loss for the year was (69.78 M) with loss before overhead, payroll, taxes, and interest of (46.73 M). | |
| Bioatla currently holds about 178.12 M in cash with (71.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from thelincolnianonline.com: BioAtla, Inc. Short Interest Down 29.9 percent in December |
Bioatla Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bioatla previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Bioatla Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.53 M.Technical Drivers
As of the 21st of January, Bioatla shows the Standard Deviation of 9.1, mean deviation of 6.32, and Risk Adjusted Performance of (0.07). Bioatla technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bioatla Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.
Bioatla Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bioatla insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bioatla's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bioatla insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bioatla Outstanding Bonds
Bioatla issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bioatla uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bioatla bonds can be classified according to their maturity, which is the date when Bioatla has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Bioatla Predictive Daily Indicators
Bioatla intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bioatla stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 252946.0 | |||
| Daily Balance Of Power | (0.50) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 0.31 | |||
| Day Typical Price | 0.31 | |||
| Price Action Indicator | (0.02) | |||
| Period Momentum Indicator | (0.02) |
Bioatla Forecast Models
Bioatla's time-series forecasting models are one of many Bioatla's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bioatla's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Bioatla Bond Ratings
Bioatla financial ratings play a critical role in determining how much Bioatla have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Bioatla's borrowing costs.| Piotroski F Score | 6 | Healthy | View |
| Beneish M Score | (2.84) | Unlikely Manipulator | View |
Bioatla Debt to Cash Allocation
As Bioatla follows its natural business cycle, the capital allocation decisions will not magically go away. Bioatla's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Bioatla currently holds 836 K in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Bioatla has a current ratio of 7.33, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Bioatla's use of debt, we should always consider it together with its cash and equity.Bioatla Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Bioatla's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Bioatla, which in turn will lower the firm's financial flexibility.Bioatla Corporate Bonds Issued
Most Bioatla bonds can be classified according to their maturity, which is the date when Bioatla has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Bioatla Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Bioatla prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bioatla shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bioatla. By using and applying Bioatla Stock analysis, traders can create a robust methodology for identifying Bioatla entry and exit points for their positions.
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California. Bioatla operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Bioatla to your portfolios without increasing risk or reducing expected return.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Complementary Tools for Bioatla Stock analysis
When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |